UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000012856
Receipt number R000015024
Scientific Title A Phase II trial of SOX plus bevacizumab or cetuximab as neoadjuvant chemotherapy in patients with locally advanced rectal cancer (OITA-trial II)
Date of disclosure of the study information 2014/01/15
Last modified on 2019/03/16 13:16:29

No. Disposal Last modified on Item of update
1 Insert 2014/01/15 16:15:14
2 Update 2014/01/20 18:16:06 Key secondary outcomes
3 Update 2019/03/16 13:16:29 Recruitment status
Date of IRB
Last follow-up date